As of June 30, 2026, Elevate Uranium Ltd. carries a market capitalization of 83.87M, placing it among publicly traded companies globally. Its enterprise value stands at 64.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 83.87M |
| Enterprise Value | 64.03M |
Elevate Uranium Ltd.'s next confirmed earnings release is scheduled for March 11, 2027.
| Earnings Date | 3/11/2027 |
As of June 30, 2026, Elevate Uranium Ltd. has 465.97M shares outstanding.
| Shares Outstanding | 465.97M |
These figures are as of June 30, 2026. The price-to-sales ratio is 747.64, and the price-to-book ratio stands at 3.43.
| PS Ratio | 747.64 |
| PB Ratio | 3.43 |
| P/TBV Ratio | 3.43 |
These figures are as of June 30, 2026. The EV/Sales ratio of 609.42 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 64.03M versus a market cap of 83.87M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 609.42 |
As of June 30, 2026, Elevate Uranium Ltd. maintains a current ratio of 14.48, meaning it holds 14.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 14.48 |
| Quick Ratio | 14.35 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | -0.02 |
As of the close on November 16, 2026, Elevate Uranium Ltd.'s stock has declined approximately 31.70% over the past 52 weeks. The 50-day moving average sits at 0.17, while the 200-day moving average is 0.20.
| 52-Week Price Change | -31.70% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.20 |
Over the twelve months ended June 30, 2026, Elevate Uranium Ltd. generated 105,064.36 in revenue and converted that into -10.68M in net income, yielding earnings per share of -0.02. EBITDA reached -11.37M, while operating income came in at -11.75M.
| Revenue | 105,064.36 |
| Gross Profit | 105,064.36 |
| Operating Income | -11.75M |
| Pretax Income | -10.79M |
| Net Income | -10.68M |
| EBITDA | -11.37M |
| EBIT | -11.56M |
| Earnings Per Share (EPS) | -0.02 |
As of June 30, 2026, Elevate Uranium Ltd. holds 19.95M in cash and equivalents against 222,992.39 in total debt, resulting in a net debt position of -19.95M. Total book value stands at 24.42M, with working capital of 18.95M providing operational flexibility.
| Cash & Cash Equivalents | 19.95M |
| Total Debt | 222,992.39 |
| Net Debt | -19.95M |
| Equity (Book Value) | 24.42M |
| Book Value Per Share | 0.05 |
| Working Capital | 18.95M |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -2.40M |
These figures cover the twelve months ended June 30, 2026. The operating margin of -11,181.60 and net profit margin of -10,168.97 provide insight into operational efficiency.
| Operating Margin | -11,181.60 |
| Pretax Margin | -10,272.22 |
| Profit Margin | -10,168.97 |
| EBITDA Margin | -10,822.45 |
These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -19.08, meaning Elevate Uranium Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -19.08 |
Elevate Uranium Ltd.'s most recent stock split took place on November 5, 2014 with a 100:1 split ratio.
| Last Split Date | 11/5/2014 |
| Split Ratio | 100:1 |
As of June 30, 2026, Elevate Uranium Ltd. has an Altman Z-Score of 28.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 28.02 |
Already premium?